What changed
Moment
Acne can persist or start around menopause. Dryness talk is not a contradiction in this review's framing.
Acne can persist or start around menopause. Dryness talk is not a contradiction in this review's framing.
Adult female acne can persist or begin de novo, including after menopause. Narrative-review language, not a cream trial.
The mechanism, in plain language
Adult female acne can persist from adolescence or begin de novo in adulthood, including after menopause. Relative androgen excess as estrogens decline during the menopausal transition is one published framing for why acne can appear, including in skin that this review also describes as dryer or more barrier-fragile in that life stage.
That is narrative-review language from Dias da Rocha et al. 2024. Not a survey of how many women feel acne and dryness at once. Not a cream trial. Industry affiliations stay visible: Pierre Fabre employees among co-authors, Pierre Fabre-funded editorial assistance, academic author disclosures.
A separate forehead Sebumeter study from the first post-menopause decade (#7) found average sebum excretion can fall while women still differ widely from each other. That is sebum context only. It does not diagnose acne. See Oily and dry can both be true if that report is the closer fit.
Honesty limits
This page explains a review. It does not tell you what your skin is doing.
- Primary: Dias da Rocha et al. 2024 narrative review. PMC11034510. Industry loud. Several co-authors are Pierre Fabre employees. Editorial assistance was Pierre Fabre-funded. Academic authors disclose Pierre Fabre and other industry relationships.
- Persist or de novo, including post-menopause.
- Menopausal transition: relative increase in androgens as estrogens decline; can manifest as acne.
- Dryness / barrier-fragility: menopause impact framing in the same review. Not a dual-endpoint prevalence study.
- #7 optional sebum context only. Already used in oily and dry. Does not diagnose acne.
- Omit Table 1 prevalence and collagen asides by default.
- No cream sold. No SisLuna. No Rx / HRT CTA. No invented dual-report percent.
Dias da Rocha MA et al. Int J Womens Health. 2024;16:663-678. doi:10.2147/IJWH.S431523
Piérard-Franchimont C, Piérard GE. Dermatology. 2002;204:17-22. doi:10.1159/000051804
Sources
- Dias da Rocha MA et al. Int J Womens Health. 2024;16:663-678. doi:10.2147/IJWH.S431523
- Piérard-Franchimont C, Piérard GE. Dermatology. 2002;204:17-22. doi:10.1159/000051804